Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Current Treatment Options in Oncology
|
September 19, 2009
Quality of life following incontinent cutaneous and orthotopic urinary diversions
Cheryl T Lee
Urologic Oncology
|
January 9, 2007
A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer
Cheryl T Lee
European Urology
|
October 12, 2014
Reply to Santosh Kumar and Aditya Prakash Sharma's letter to the editor re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol 2014;66:265-72
Cheryl T Lee
Journal of the National Cancer Institute
|
May 6, 2004
Re: Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer
Cheryl T Lee
Current Opinion in Urology
|
September 29, 2015
Health-related quality of life with urinary diversion
Hamed Ahmadi, Cheryl T Lee
JAMA Surgery
|
June 13, 2019
Closing the Loop on the Role of Multiparametric Magnetic Resonance Imaging-Targeted Prostate Biopsy
Ahmad Shabsigh, Cheryl T Lee
Current Opinion in Urology
|
March 15, 2018
Frailty and geriatric assessment in urologic oncology
Tyler Sheetz, Cheryl T Lee
Annals of Surgical Oncology
|
February 1, 2024
Paradigm Shifting Research: Key Studies in Urologic Oncology
Shawn Dason, Cheryl T Lee
Nature Clinical Practice. Urology
|
February 10, 2007
Treatment of muscle-invasive bladder cancer: is cystectomy enough?
Cheryl T Lee, James E Montie
BJU International
|
November 28, 2008
Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making
Cheryl T Lee, David M Latini
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Current Treatment Options in Oncology
|
September 19, 2009
Quality of life following incontinent cutaneous and orthotopic urinary diversions
Cheryl T Lee
Urologic Oncology
|
January 9, 2007
A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer
Cheryl T Lee
European Urology
|
October 12, 2014
Reply to Santosh Kumar and Aditya Prakash Sharma's letter to the editor re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol 2014;66:265-72
Cheryl T Lee
Journal of the National Cancer Institute
|
May 6, 2004
Re: Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer
Cheryl T Lee
Current Opinion in Urology
|
September 29, 2015
Health-related quality of life with urinary diversion
Hamed Ahmadi, Cheryl T Lee
JAMA Surgery
|
June 13, 2019
Closing the Loop on the Role of Multiparametric Magnetic Resonance Imaging-Targeted Prostate Biopsy
Ahmad Shabsigh, Cheryl T Lee
Current Opinion in Urology
|
March 15, 2018
Frailty and geriatric assessment in urologic oncology
Tyler Sheetz, Cheryl T Lee
Annals of Surgical Oncology
|
February 1, 2024
Paradigm Shifting Research: Key Studies in Urologic Oncology
Shawn Dason, Cheryl T Lee
Nature Clinical Practice. Urology
|
February 10, 2007
Treatment of muscle-invasive bladder cancer: is cystectomy enough?
Cheryl T Lee, James E Montie
BJU International
|
November 28, 2008
Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making
Cheryl T Lee, David M Latini
Page
of 13